|
|
||||||||
Original Research Communication |
1 From the Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland (KSJ and HMM); the Department of Medicine, Kuopio University Hospital, Kuopio, Finland (DEL and LKN); and VTT Biotechnology, Espoo, Finland (KSP).
2 Supported by Fazer Bakeries Ltd, Vaasan & Vaasan Oy, and the Technology Development Center of Finland.
3 Address reprint requests to K Juntunen, Department of Clinical Nutrition, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland. E-mail: katri.juntunen{at}uku.fi.
| ABSTRACT |
|---|
|
|
|---|
Objective: The aim was to study whether the long-term use of high-fiber rye bread and white-wheat bread modifies glucose and insulin metabolism in healthy postmenopausal women.
Design: The study was a randomized crossover trial consisting of 8-wk test and 8-wk washout periods. The subjects were 20 postmenopausal women [
± SD age: 59 ± 6.0 y; body mass index (in kg/m2): 27.5 ± 2.9; baseline fasting serum cholesterol: 6.5 ± 0.8 mmol/L], of whom 3 had impaired glucose tolerance as determined by a 2-h oral-glucose-tolerance test. The test breads were high-fiber rye and white-wheat breads, planned to make up
20% of energy. Fasting blood samples were collected for the measurement of plasma glucose and insulin at the beginning and at the end of both bread periods. The frequently sampled intravenous-glucose-tolerance test was performed at the run-in and at the end of both bread periods. The acute insulin response, insulin sensitivity, and glucose effectiveness were calculated.
Results: The rye bread made up 23.4 ± 4.3% and wheat bread 26.7 ± 8.2% of total energy intake. Compared with that during the run-in period, the acute insulin response increased significantly more during the rye bread period (9.9 ± 24.2%) than during the wheat bread period (2.8 ± 36.3%; P = 0.047). Other measured variables did not change significantly during the study.
Conclusions: Modification of carbohydrate intake by high-fiber rye bread did not alter insulin sensitivity in postmenopausal, hypercholesterolemic women. High-fiber rye bread appears to enhance insulin secretion, possibly indicating improvement of b cell function.
Key Words: Rye wheat fiber insulin sensitivity insulin secretion glucose women
| INTRODUCTION |
|---|
|
|
|---|
Women undergoing menopause display decreased insulin sensitivity (6), insulin secretion (7), and hepatic insulin extraction (8). Loss of ovarian function with consequent effects on hormone metabolism (9) and possible changes in body composition (10) may partly explain why womens susceptibility to diabetes and cardiovascular disease becomes more pronounced after menopause.
We previously showed in healthy individuals that ingestion of whole-kernel rye bread compared with white-wheat bread reduces postprandial insulin, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide 1 (GLP-1) concentrations (11, 12). Whether these short-term favorable effects on insulin metabolism are reflected in long-term reductions in insulin resistance, enhancement of insulin clearance, or improved insulin secretion has not been previously reported. In the present study, we sought to determine the changes in glucose and insulin metabolism as assessed by a frequently sampled intravenous-glucose-tolerance test (FSIGTT) in response to long-term use of high-fiber rye bread and white-wheat bread by using a randomized crossover design in healthy, postmenopausal women.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Height, weight, systolic and diastolic blood pressure, routine hematologic measures, and serum creatinine, thyroxine, and liver enzyme concentrations were measured before entry into the study (Table 1
). For the 4 subjects with treated hypothyroidism, concentrations of thyroid-stimulating hormone were normal. All other subjects had normal thyroid function. All women had normal liver and kidney function. The primary inclusion criteria for the study were a serum total cholesterol concentration of 5.08.5 mmol/L, a non-HDL-cholesterol concentration of 3.56.5 mmol/L (calculated as serum total cholesterol - serum HDL cholesterol), a serum total triacylglycerol concentration < 2.5 mmol/L, and body mass index (in kg/m2) of 2033. Exclusion criteria included the use of lipid-lowering, laxative, or corticosteroid medication and diagnosed or undiagnosed diabetes mellitus. The glucose tolerance of the subjects was screened by use of an oral-glucose-tolerance test (World Health Organization criteria; 13). Only 3 women had impaired glucose tolerance as diagnosed by the 2-h glucose concentration after a glucose load, and none had impaired fasting glucose. Postmenopausal status was confirmed by measuring serum follicle-stimulating hormone concentrations. Thirteen subjects used low-dose postmenopausal medication by mouth, skin, or vagina; 4 subjects taking oral medication also had menstrual flow.
|
After the run-in period, the subjects were randomly assigned into either an 8-wk rye bread or an 8-wk wheat bread period. There was an 8-wk washout period between the bread periods, during which the subjects ate their usual diet. The FSIGTTs were performed during the run-in period and at the end of the rye and wheat bread periods. The mean of 2 measurements (-5 and 0 min) before the FSIGTT was used as the fasting value for plasma glucose and insulin at the end of the bread periods. In addition, one blood sample was taken at the beginning of the bread periods for the measurement of fasting plasma glucose and insulin concentrations. The subjects were weighed every 2 wk. Subjects were asked to record daily exercise during the 2-wk baseline period and the bread periods.
The duration of the test bread periods and the washout period between the bread periods was adjusted to cycle length in those women using low-hormone oral postmenopausal medication and who consequently had menstrual flow. Their blood samples were collected at the same phase of the menstrual cycle, except in one subject as the result of scheduling problems.
Diet
The test breads were intended to cover a minimum of 20% of daily energy intake. The high-fiber rye bread (
17% dietary fiber) was prepared by increasing the content of rye bran in the bread. To increase compliance with consumption of the high-fiber rye bread during the 8-wk bread period, 2 commercial bakeries (Fazer Bakeries Ltd, Lahti, Finland and Vaasan & Vaasan Oy, Helsinki) made from the basic recipe 4 products varying in appearance but with similar nutrient composition. The rye breads were baked in 2 lots, one for those who started with the rye bread and one for those who ate rye bread during the second bread period. The breads were stored (-18°C) until given to the subjects at the visits to the study center. Seven different white-wheat breads (
2.8% dietary fiber) produced from refined wheat flour were offered during the wheat bread period. These freshly baked, commercially used breads were available once a week from the study center. The wheat breads were also supplied from the 2 above-mentioned bakeries.
To guarantee that the subjects ate the correct amount of the test breads, they were given detailed instructions on how to slice the loaves and how to combine the daily portions of different products. It was easier for the subjects to estimate the amount of test breads to be consumed as slices rather than as grams, and no kitchen scales for estimating the amount of bread to be consumed were used. The portions of rye breads weighed 24.128.1 g and those of wheat breads, 20.825.0 g. One portion of rye bread contained on average 206 kJ (range: 174234 kJ) and 4.4 g fiber (range: 4.14.6 g); the respective values for wheat bread were 241 kJ (range: 233249 kJ) and 0.6 g (range: 0.50.8 g). Because the energy content of the bread portions varied, the subjects were advised to eat approximately the same amount of each product during the week. A minimum of 45 portions of the test breads had to be eaten each day, and the number of portions to be eaten varied according to the daily energy intake of the individual. There was no maximum for the amount of bread to be consumed, but the subjects were advised to eat the bread in amounts corresponding to cereal consumption in their habitual diet.
The dietary advice to the subjects was similar to that in our previous study on the effects of rye bread on lipid metabolism in hypercholesterolemic men and women (14). The only change in the diet was to replace the customarily used breads and baked products with rye breads during the rye bread period and with wheat breads during the wheat bread period. In addition to the test breads, the subjects could eat a piece of sweet pastry or a portion of porridge once a day, but it was not obligatory. The latter products were recommended to be rye-based products during the rye bread period and wheat-based products during the wheat bread period. Pasta and rice could be eaten as part of warm dishes in amounts usually eaten by the subject. Otherwise, the diet was to be maintained unchanged. The subjects were especially advised not to change the amount and type of fat and cold cuts eaten with the breads or the use of fiber-containing foods such as vegetables, fruit, and berries.
Compliance with the diet was checked by daily records on the use of breads and by 4-d food records. The subjects kept daily records of the number of portions of the test rye or wheat breads that were eaten as well as the quantity, quality, and frequency of other cereals that were consumed. Four-day food records that included one weekend day were kept by the subjects during weeks 46 in both bread periods.
The clinical nutritionist (KSJ) advised the subjects on the practical management of the diet. All 4-d food records were analyzed by the clinical nutritionist with the MICRO-NUTRICA calculation program for nutrients (version 2.0; Finnish Social Insurance Institute, Turku, Finland), which included the database of Finnish foods (15). The nutrient composition of the rye and wheat breads used in the study was analyzed at VTT Biotechnology (Espoo, Finland) and added to the database.
Frequently sampled intravenous-glucose-tolerance test
The subjects arrived at the study center in the morning after they had fasted overnight (12 h). Smoking was forbidden on the morning the test was conducted, and the subjects were asked to travel to the laboratory by car or by bus if possible to avoid extra physical activity. After arrival, they were weighed (light clothing, no shoes) on a digital scale.
The minimal model FSIGTT was performed as described by Bergman (16). First, 2 intravenous catheters were inserted into the antecubital veins in both arms. After the catheters were inserted, the patients rested in a supine position for 10 min before the fasting samples were drawn. A glucose dose of 330 mg/kg body wt was given intravenously as a 50% solution in 1.5 min followed by 10 mL of a 0.9% NaCl solution. Thereafter, a 0.9% NaCl solution was slowly infused until a bolus of 0.03 U insulin/kg was rapidly injected 20 min after the glucose dose. NaCl was then rapidly infused for 1.5 min after the insulin dose. To measure plasma glucose and insulin concentrations, venous blood samples were collected before the glucose dose (-5 and 0 min) and 23 times after the glucose dose (at 2, 4, 6, 8, 10, 12, 14, 16, 19, 22, 24, 27, 30, 40, 50, 60, 70, 90, 100, 120, 140, 160, and 180 min) via a catheter in the contralateral arm. To arterialize the venous blood, the arm was kept in a 50°C electric pad during the test.
The plasma samples were collected in prechilled tubes containing EDTA for measurement of insulin and in prechilled tubes containing fluoride citrate for measurement of glucose and were centrifuged within 30 min of the time of blood collection for 15 min at 2100 x g and -4°C. The plasma was separated, and the samples were stored at -20°C until analyzed. Plasma glucose was analyzed by the enzymatic photometric method (Granutest 100; Merck, Damstadt, Germany) in a Kone Specific Clinical Analyser (Kone Ltd, Espoo, Finland); plasma insulin was analyzed by radioimmunoassay (Phadaseph Insulin RIA 100; Pharmacia Diagnostica, Uppsala, Sweden). The between-assays CVs were 1.80% (n = 39) and 1.48% (n = 39) for the lowest and highest glucose controls, respectively, and 7.22% (n = 21), 3.31% (n = 21), and 4.74% (n = 21) for the lowest, middle, and highest insulin controls, respectively.
Glucose effectiveness (SG) and insulin sensitivity (SI) indexes were calculated with the MINMOD program (17). In addition, the acute insulin response (AIR) was determined by calculating the area under the insulin curve above the baseline concentration from 0 to 10 min.
Statistical analysis
Percentage changes in nutrient intakes from the run-in period to the rye bread period and from the run-in period to the wheat bread period were calculated. Because all values were not normally distributed even after logarithmic transformations, the comparisons were made with Wilcoxons rank-sum test for dependent data. Because the changes in energy intakes from protein and total fat over the rye bread period were different from the changes over the wheat bread period, the differences in these protein and fat variables were used as covariates in the covariance analysis.
Normal distribution and homogeneity of variance were checked, and logarithmic transformations were made for all the variables included in covariance analysis if needed. However, untransformed values are presented in Tables 4 and 5![]()
. The changes in body weight and fasting plasma glucose and insulin concentrations at the beginning and at the end of the bread periods were analyzed by covariance analysis of repeated measures (18).
|
|
The comparison in the single measurement points during the FSIGTT and in the frequency of exercise among the run-in, rye bread, and wheat bread periods was made by using the nonparametric Friedmans test for the dependent data. To compare the changes in fasting glucose and insulin, SG, SI, and AIR during the rye bread and wheat bread periods according to glucose tolerance, use of thyroid hormone and estrogen replacement therapy, and body weight, the nonparametric Mann-Whitney U test for independent samples was used. In all analyses, P values < 0.05 were considered to be statistically significant. The results are expressed as means ± SDs. Data were analyzed with SPSS for WINDOWS 8.0. (SPSS Inc, Chicago) (19, 20).
| RESULTS |
|---|
|
|
|---|
|
|
Fasting plasma insulin and glucose
The fasting plasma glucose and insulin values are shown in Table 4
. Even though the plasma insulin values seemed to decrease during both the rye bread and the wheat bread periods, the changes were not significant (P = 0.993). Bread type had a significant effect (P = 0.006) on overall insulin concentrations during the study. There was no significant interaction with time, however, indicating that there was no significant effect of bread type on the changes in insulin during the periods. Overall, plasma glucose concentrations also did not change during the bread periods (P = 0.958), nor did bread type affect the changes in plasma glucose during the bread periods. Dietary protein and total fat had a significant association with plasma glucose (P = 0.028 and P = 0.048, respectively), although no significant changes in plasma glucose occurred during either the rye bread or the wheat period.
Frequently sampled intravenous-glucose-tolerance test
The plasma glucose and insulin curves during the FSIGTT are shown in Figure 1
. There were no consistent differences at single measurement points in either glucose or insulin during the FSIGTT: plasma glucose concentrations were different at 2 (P = 0.035) and 140 (P = 0.016) min, and insulin concentration at 50 min (P = 0.019) among the run-in and the test bread periods. The values of the SG, SI, and AIR at the run-in and at the end of the rye and wheat bread periods are shown in Table 5
. The differences in SG and SI between the rye bread and the wheat bread periods were not significant (P = 0.522 and P = 0.170, respectively). Protein had a significant association with SI (P = 0.008), although SI did not significantly change during the study.
|
| DISCUSSION |
|---|
|
|
|---|
The possible confounding effects were minimized by study design, with each subject serving as her own control. Body weight, energy intake, alcohol consumption, and the frequency of exercise also remained constant during the study. In addition, the greater percentage increase in protein intake and the greater percentage decrease in fat intake during the rye bread period than during the wheat bread period were taken into account by using these as covariates. Glucose tolerance, use of thyroid hormone or hormone replacement therapy, and body mass index did not significantly affect the results.
We have considered 2 possible mechanisms for the increased acute insulin response after the rye bread period. The most obvious explanation for this finding is that the lente properties of rye fiber modify the digestion and absorption of carbohydrates in the small intestine and consequently the secretion of insulin from the pancreas. Second, rye may contain specific compounds that enhance the acute phase of insulin secretion. Such compounds may include phenolic acids and tannins, which are benzoic acid and phenylalanine derivatives (21, 22). The latter compounds have recently been described as short-acting prandial drugs that stimulate insulin secretion (23, 24), in contrast with the slower-onset and long-acting sulfonylureas. The mechanism of action of these compounds includes enhancing the function of potassium channels in pancreatic ß cells, which play a decisive role in the generation of the acute insulin response (25).
The high-fiber content of the rye products may explain their lente effects after ingestion. Soluble fibers produce viscous solutions that may interfere with hydrolysis by binding enzymes and nutrients to the fiber, reducing the surface area of the food particles available for digestion, altering the intraluminal mixing and contractability, and reducing the rate of diffusion through the intraluminal contents of the small intestine to enterocytes (26, 27). In addition, the end products of fiber fermentation in large bowel, such as propionic and butyric acids, may have insulinotropic effects (28).
It is possible that lower postprandial insulin responses after consumption of rye bread than after wheat bread (11, 12) occurring repeatedly over longer periods of time result in "relief" of overstimulation of ß cells and correction of ß cell dysfunction (29). The loss of the acute insulin response is one of the earliest defects in the development of type 2 diabetes, and it is found already in subjects at high risk (25). It is therefore tempting to speculate in light of the present results and our earlier postprandial studies that long-term ingestion of rye bread could protect the pancreatic ß cells from exhaustion or even enhance ß cell function.
Insulin sensitivity can be measured in many different ways. As a more sophisticated method, calculations of SI and SG from the minimal model FSIGTT were used in the present study. Although SI seemed to be affected by the intake of protein, no significant differences either in proportional changes of SI during the rye bread and the wheat bread periods compared with the run-in period or in the pairwise comparisons between the run-in and the end of the bread periods were observed. SG was also unaltered during the rye bread and wheat bread periods. Earlier studies of the long-term effects of different cereal foods on indexes modifying insulin action and glucose metabolism in peripheral tissues in healthy elderly women are lacking. There is one earlier study with fat-carbohydrate modification of the diet in postmenopausal women (30), but the different study design and diets do not allow us to compare those results with those of the present study.
No significant changes in fasting glucose and insulin concentrations, which are crude measures of insulin sensitivity, were found in the present study. Although bread type seemed to have some effect on insulin, and the intakes of protein and total fat had some interaction with plasma glucose, these findings are of questionable importance because insulin and glucose concentrations remained unchanged throughout the study. The finding of unchanged fasting glucose and insulin concentrations confirms our earlier finding in hypercholesterolemic men and women who ate commercial rye and white-wheat breads for 4 wk in random order (14). One previous study showed that consumption of a high-carbohydrate, high-fiber diet compared with the usual ad libitum diet could decrease both fasting glucose and insulin in elderly men and women (31). However, in that trial, the intakes of carbohydrates and fiber were considerably greater than in the present study (68% compared with 53% of energy and 68 compared with 46 g/d, respectively). In agreement with our results, no alteration of the fasting glucose or insulin concentrations was observed after consumption of a high-carbohydrate diet (60% of energy) by elderly men and women with impaired glucose tolerance for 12 wk (32), after consumption of a low-glycemic-index diet by elderly men and women with coronary heart disease for 4 wk (33), and after supplementation of the diet with guar gum (15 g/d) in perimenopausal women for 6 mo (34).
The lack of effect of the dietary carbohydrate and fiber modifications on fasting glucose and insulin concentrations remains unexplained. Some studies have consistently shown postprandially improved glycemic and insulinemic responses with the consumption of low-glycemic-index foods (35), whole-grain bread (36), and increased amounts of fiber from naturally high-fiber foodstuffs (37). In addition, epidemiologic evidence suggests that the consumption of foods with a low glycemic index and high in dietary fiber and whole-grain cereals may prevent diabetes (2, 4). It is possible that modification of carbohydrate and fiber intake alters fasting insulin and glucose concentrations and insulin sensitivity only after much longer time periods in nondiabetic individuals.
Rye bread increased the acute insulin response to a minimal model glucose tolerance test in postmenopausal women, suggesting that high-fiber rye bread may have favorable long-term effects on the maintenance of normal ß cell secretion or on the improvement of pancreatic ß cell dysfunction. Further studies should, however, confirm these results and evaluate the mechanism and the components in rye that are responsible for this effect.
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Kallio, M. Kolehmainen, D. E Laaksonen, L. Pulkkinen, M. Atalay, H. Mykkanen, M. Uusitupa, K. Poutanen, and L. Niskanen Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1497 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Weickert and A. F. H. Pfeiffer Metabolic Effects of Dietary Fiber Consumption and Prevention of Diabetes J. Nutr., March 1, 2008; 138(3): 439 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wolever, A. L Gibbs, C. Mehling, J.-L. Chiasson, P. W Connelly, R. G Josse, L. A Leiter, P. Maheux, R. Rabasa-Lhoret, N W. Rodger, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein Am. J. Clinical Nutrition, January 1, 2008; 87(1): 114 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wolever, J. C Brand-Miller, J. Abernethy, A. Astrup, F. Atkinson, M. Axelsen, I. Bjorck, F. Brighenti, R. Brown, A. Brynes, et al. Measuring the glycemic index of foods: interlaboratory study Am. J. Clinical Nutrition, January 1, 2008; 87(1): 247S - 257S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Andersson, S. Tengblad, B. Karlstrom, A. Kamal-Eldin, R. Landberg, S. Basu, P. Aman, and B. Vessby Whole-Grain Foods Do Not Affect Insulin Sensitivity or Markers of Lipid Peroxidation and Inflammation in Healthy, Moderately Overweight Subjects J. Nutr., June 1, 2007; 137(6): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kallio, M. Kolehmainen, D. E Laaksonen, J. Kekalainen, T. Salopuro, K. Sivenius, L. Pulkkinen, H. M Mykkanen, L. Niskanen, M. Uusitupa, et al. Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1417 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. G.E. Zarraga and E. R. Schwarz Impact of Dietary Patterns and Interventions on Cardiovascular Health Circulation, August 29, 2006; 114(9): 961 - 973. [Full Text] [PDF] |
||||
![]() |
M. K Jensen, P. Koh-Banerjee, M. Franz, L. Sampson, M. Gronbaek, and E. B Rimm Whole grains, bran, and germ in relation to homocysteine and markers of glycemic control, lipids, and inflammation 1 Am. J. Clinical Nutrition, February 1, 2006; 83(2): 275 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N Davis, E. E Ventura, M. J Weigensberg, G. D. Ball, M. L Cruz, G. Q Shaibi, and M. I Goran The relation of sugar intake to {beta} cell function in overweight Latino children Am. J. Clinical Nutrition, November 1, 2005; 82(5): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Linko, K. S. Juntunen, H. M. Mykkanen, and H. Adlercreutz Whole-Grain Rye Bread Consumption by Women Correlates with Plasma Alkylresorcinols and Increases Their Concentration Compared with Low-Fiber Wheat Bread J. Nutr., March 1, 2005; 135(3): 580 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K Jensen, P. Koh-Banerjee, F. B Hu, M. Franz, L. Sampson, M. Gronbaek, and E. B Rimm Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1492 - 1499. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nestel, M. Cehun, and A. Chronopoulos Effects of long-term consumption and single meals of chickpeas on plasma glucose, insulin, and triacylglycerol concentrations Am. J. Clinical Nutrition, March 1, 2004; 79(3): 390 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. McKeown, J. B. Meigs, S. Liu, E. Saltzman, P. W.F. Wilson, and P. F. Jacques Carbohydrate Nutrition, Insulin Resistance, and the Prevalence of the Metabolic Syndrome in the Framingham Offspring Cohort Diabetes Care, February 1, 2004; 27(2): 538 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S Juntunen, D. E Laaksonen, K. Autio, L. K Niskanen, J. J Holst, K. E Savolainen, K.-H. Liukkonen, K. S Poutanen, and H. M Mykkanen Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread Am. J. Clinical Nutrition, November 1, 2003; 78(5): 957 - 964. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |